Production (Stage)
E
XBiotech Inc. XBIT
$2.84 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments -22.45% -13.67% -9.43% -7.93% -5.47%
Total Receivables -32.49% -8.24% -34.61% -73.83% -67.63%
Inventory -- -- -- -- --
Prepaid Expenses 7.28% 35.79% 18.89% 17.85% 52.49%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -22.34% -13.46% -9.48% -9.01% -6.12%

Total Current Assets -22.34% -13.46% -9.48% -9.01% -6.12%
Net Property, Plant & Equipment -2.51% -1.49% -1.51% -2.76% -4.01%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets -20.19% -12.14% -8.60% -8.33% -5.89%

Total Accounts Payable -57.81% -11.65% 2.59% -6.17% 92.11%
Total Accrued Expenses 2.60% -24.82% 22.33% 103.04% 90.12%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -91.57% -- -- -- 50.91%
Total Other Current Liabilities -91.57% -- -- -- 50.91%
Total Current Liabilities -67.96% 147.62% 202.08% 285.06% 366.67%

Total Current Liabilities -67.96% 147.62% 202.08% 285.06% 366.67%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 2.77% 3.06% 5.95% 5.91% 6.01%
Total Liabilities -61.51% 116.57% 155.56% 210.46% 256.17%

Common Stock & APIC 1.78% 0.72% 0.95% 1.15% 1.33%
Retained Earnings -63.26% -73.66% -68.51% -86.85% -97.40%
Treasury Stock & Other -- -- -- -- --
Total Common Equity -16.52% -16.71% -13.72% -14.13% -11.66%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -16.52% -16.71% -13.72% -14.13% -11.66%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -16.52% -16.71% -13.72% -14.13% -11.66%